Patents by Inventor Krestian Larsen

Krestian Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240327336
    Abstract: The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.
    Type: Application
    Filed: December 6, 2022
    Publication date: October 3, 2024
    Applicant: H. Lundbeck A/S
    Inventors: Mario Rottlander, Xiaofang Wang, Debasis Das, Jian Hong, Shu Hui Chen, Anette Graven Sams, Krestian Larsen
  • Patent number: 11548849
    Abstract: The present invention provides novel compounds (e.g., compounds of Formula I) which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.
    Type: Grant
    Filed: July 30, 2020
    Date of Patent: January 10, 2023
    Assignee: H. Lundbeck A/S
    Inventors: Mario Rottlander, Xiaofang Wang, Debasis Das, Jian Hong, Shu Hui Chen, Anette Graven Sams, Krestian Larsen
  • Publication number: 20210032196
    Abstract: The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.
    Type: Application
    Filed: July 30, 2020
    Publication date: February 4, 2021
    Inventors: Mario Rottlander, Xiaofang Wang, Debasis Das, Jian Hong, Shu Hui Chen, Anette Graven Sams, Krestian Larsen
  • Patent number: 7544685
    Abstract: The invention relates to compounds of the formula I wherein the variables are as defined in the claims. The compounds are useful in the treatment of a disease where a D4 receptor and/or a 5-HT2A receptor is implicated.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: June 9, 2009
    Assignee: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Krestian Larsen, Niels Mørk
  • Publication number: 20070043058
    Abstract: The invention relates to compounds of the formula I wherein the variables are as defined in the claims. The compounds are useful in the treatment of a disease where a D4 receptor and/or a 5-HT2A receptor is implicated.
    Type: Application
    Filed: August 15, 2006
    Publication date: February 22, 2007
    Inventors: Benny Bang-Andersen, Krestian Larsen, Niels Mork
  • Publication number: 20030162792
    Abstract: The present invention relates to an indole derivative having the formula 1
    Type: Application
    Filed: December 11, 2002
    Publication date: August 28, 2003
    Applicant: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Krestian Larsen, Jan Kehler